Dec 01, 2021 / 09:20PM GMT
Vijay Muniyappa Kumar - Evercore ISI Institutional Equities, Research Division - Senior MD
Okay. Good afternoon, everyone. Thanks for joining us this afternoon. A real pleasure to have Bio-Techne. It's think about life science tools companies, it's the one that got away, the one that we seldom cover as biotech. I'm excited to hear what Jim has to say. From the company, we have CFO, Jim Hippel. I think in the background, we have David Clair, who runs Investor Relations.
Jim, thank you for taking the time this afternoon.
James T. Hippel - Bio-Techne Corporation - Executive VP of Finance & CFO
Yes, you bet. We haven't gotten away, Vijay. There's plenty of -- growth.
Questions and Answers:
Vijay Muniyappa Kumar - Evercore ISI Institutional Equities, Research Division - Senior MDThat's a good one, Jim. So, maybe on that note, right? And again, apologies if some of my questions are big picture basic. I was looking at your presentation with clearly, the organic has inflected, right? When I looked at your
Trustpilot
